Celltrion

A leading force in the Korean pharmaceutical industry, Celltrion achieved a milestone by launching the world's first antibody biosimilar from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered several uncharted areas of biopharmaceutical development and plans to continue growing as a global biopharmaceutical company with unique approaches to small-molecule pharmaceuticals and new business areas such as ubiquitous healthcare platforms.